GoviEx Uranium Inc. announced a bought deal of 22,750,000 units at an issue price of CAD 0.22 per unit for aggregate gross proceeds of CAD 5,005,000 on October 3, 2022. Each unit will consist of one Class A common share of the Company and one-half of one Common Share purchase warrant. Each Warrant will entitle the holder thereof to purchase one Common Share at the exercise price of CAD 0.33 for a period of 3 years following the closing of the transaction.

The company shall grant the Underwriters an over-allotment option exercisable in whole or in part, on or before the date that is five business days prior to the closing, in the sole discretion of the Underwriters, to purchase from the treasury of the company up to an additional number of units as is equal to 15% of the number of the units issued pursuant to the offering, on the same terms as set forth above, to cover over-allotments, if any, and for market stabilization purposes. The transaction is expected to close on or about October 20, 2022, or such other date as agreed between the Company and the Underwriters, and is subject to certain conditions including, but not limited to, the receipt of all necessary corporate and regulatory approvals, including the approval of the TSX Venture Exchange. All securities issued pursuant to the transaction will have a hold period of four months and one day.